Publication
Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic review.
Journal Paper/Review - Feb 25, 2022
Xiao Yingqi, Guyatt Gordon, Zeng Linan, Rw Jayne David, A Merkel Peter, Ac Siemieniuk Reed, Dookie Jared E, A Buchan Tayler, Ahmed Muhammad Muneeb, J Couban Rachel, Mahr Alfred, Walsh Michael
Units
PubMed
Doi
Contact
Citation
Xiao Y, Guyatt G, Zeng L, Rw Jayne D, A Merkel P, Ac Siemieniuk R, Dookie J, A Buchan T, Ahmed M, J Couban R, Mahr A, Walsh M. Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic review. BMJ Open 2022; 12:e050507.
Type
Journal Paper/Review (English)
Journal
BMJ Open 2022; 12
Publication Date
Feb 25, 2022
Issn Electronic
2044-6055
Pages
e050507
Brief description/objective
To compare the efficacy and safety of alternative glucocorticoids (GCs) regimens as induction therapy for patients with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis.